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Abstract
Background and objectives: Kinsbourne syndrome is a rare neurological disorder that primarily 
affects children previously healthy and aged between 6 and 36 months. It is characterized by 
opsoclonus (rapid, irregular, horizontal and vertical eye movements) and myoclonus that may 
affect trunk, limbs or face, and cerebellar ataxia. It may be considered a paraneoplastic syndrome 
by association with neuroblastomas, hepatoblastomas and, rarely, ganglioneuromas. The aim 
of this paper was to present the most relevant aspects of Kinsbourne syndrome, as well as the 
technique used for resection of mediastinal tumor in a child with this syndrome.
Case report: Child, 1 year and 5 months, with a diagnosis of posterior mediastinal tumor and 
Kinsbourne syndrome. Premedicated with oral midazolam. Anesthesia induced with sevoﬂ urane, 
nitrous oxide, fentanyl, and rocuronium. Maintenance of anesthesia with sevoﬂ urane, nitrous 
oxide, fentanyl, and rocuronium. Neuromuscular block reversal with neostigmine combined with 
atropine. Postoperative analgesia with the use of dipyrone, morphine, and ketoprofen. Taken 
to the intensive care unit extubated, with stable hemodynamic and respiratory parameters. ICU 
discharge four days after surgery and hospital discharged on the seventh postoperative day without 
complications. Anatomopathological examination revealed ganglioneuroblastoma.
Conclusions: Kinsbourne syndrome is a rare neurological disorder. The drugs used in our patient 
proved safe and allowed an uneventful anesthesia. Drugs that trigger or aggravate opsoclonus 
and myoclonus, such as ketamine and etomidate, should be avoided in these patients.
© 2013 Sociedade Brasileira de Anestesiologia. Published by Elsevier Editora Ltda. 
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Introduction
Kinsbourne syndrome, known as opsoclonus-myoclonus-
ataxia, described in 1962 by Marcel Kinsbourne, is a rare 
neurological disorder that primarily affects previously 
healthy children, aged between 6 and 36 months, and is 
characterized by the presence of opsoclonus (rapid, irregu-
lar, horizontal and vertical eye movements) and myoclonus 
that may affect trunk, limbs or face, and cerebellar ataxia. 
It may be considered a paraneoplastic syndrome by asso-
ciation with neuroblastomas, hepatoblastomas and, rarely, 
ganglioneuromas 1-3.
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The objective of this case report was to present the anes-
thetic management of a child with Kinsbourne syndrome who 
underwent resection of posterior mediastinal tumor.
Case report
Female patient, 1 year and 5 months old, admitted at the 
Oncology Center of the Hospital Universitário Oswaldo Cruz, 
in Recife, with a clinical picture of opsoclonus, myoclonus, 
ataxia, and irritability, diagnosed with Kinsbourne syndrome. 
Due to the association with neuroblastoma, an investigation 
was performed for the diagnosis of neoplasia. The total body 
scintigraphy with MIBG-I-131 showed a large area of focal 
hyperuptake of radioactive agent, located in the posterior 
mediastinum and suggestive of neuroectodermal lineage 
malignancy (neuroblastoma). Chest computed tomography 
(CT) showed the presence of a solid and heterogeneous mass 
occupying the right paravertebral region at the level of the 
thoracic segments T3-T6, measuring approximately 3.5 x 1.3 
cm in its largest diameter, with heterogeneous impregnation 
by means of intravenous contrast. Resection of a posterior 
mediastinal tumor was scheduled through a right posterola-
teral thoracotomy.
In the pre-anesthetic evaluation, the child presented with 
a clinical picture of opsoclonus, myoclonus of face, trunk and 
extremities, and irritability, which, according to her mother, 
had started about a month. The mother reported the occur-
rence of frequent falls, a daughter of singleton pregnancy 
from healthy parents. The child was delivered by cesarean 
section. The mother denied other diseases, drug allergies or 
previous hospitalizations; she was taking clonazepam, cepha-
lexin, and prednisone. The mother also reported agitation 
with the use of midazolam, diazepam, and chloral hydrate; 
general anesthesia to undergo CT without complications. 
Upon physical examination, the child weighed 12.5 kg, was 
in good general condition, afebrile, hydrated, and without 
cyanosis. Pulmonary auscultation revealed coarse breath 
sounds without adventitious sounds, respiratory rate of 28 
rpm. Cardiac auscultation revealed a regular heart rhythm 
in two stages, normal sounds without murmurs, heart rate of 
120 bpm, and blood pressure of 90 x 40 mm Hg. The abdomen 
was ﬂ at, depressible, and without visceromegalies. Additional 
examinations were as follows: unchanged electrocardiogram, 
chest X-rays, blood count and coagulation. She was classiﬁ ed 
as ASA II. Premedication was midazolam 0.8 mg.kg-1. There 
was induction of anesthesia with sevoﬂ urane and nitrous 
oxide, as well as monitoring with ECG, pulse oximetry, and 
noninvasive blood pressure. A peripheral vein in the left 
arm with 22G teﬂ on catheter was secured. We performed 
a tracheal intubation with an uncuffed tube (4.5 mm) after 
the use of fentanyl (5 μg.kg-1) and rocuronium (0.9 mg.kg-1). 
We monitored using capnography and urinary catheter. We 
controlled ventilation with a tidal volume of 8 mL.kg-1 and 
respiratory rate of 14 rpm in CO2 rebreathing system. Right 
external jugular vein dissection was performed and catheter 
inserted. Sevoﬂ urane, nitrous oxide, and additional doses 
of fentanyl and rocuronium were used for maintenance 
of anesthesia. Before the surgical incision, hydrocortisone 
30 mg was administered. The posterior mediastinal tumor 
resection, measuring approximately 3 x 3 x 4 cm, was made 
in the paravertebral region at the level of the azygos vein, 
uneventfully. We did not use blood products. After tumor 
removal, we used dipyrone 30 mg.kg-1, ketoprofen 2 mg.kg-1, 
and morphine 0.1 mg.kg-1 for postoperative analgesia. During 
the surgical anesthetic procedure, there were no clinically 
signiﬁ cant changes in monitored parameters (heart rate and 
rhythm, blood pressure, oxygen saturation, and ETCO2). At 
the end of surgery, we performed reversal of neuromuscular 
block with atropine sulfate (0.02 mg.kg-1) and neostigmine 
(0.04 mg.kg-1). The patient was taken to the ICU extubated, 
calm, 96% SatO2 in room air with hemodynamic stability. The 
patient progressed satisfactorily, was discharged from the ICU 
four days after the surgery and, on the seventh postoperative 
day, left the hospital showing slight improvement of opsoclo-
nus and myoclonus. Anatomopathological examination of the 
resected tumor revealed paraspinal ganglioneuroblastoma.
Discussion
Kinsbourne syndrome is characterized by the presence of 
opsoclonus, myoclonus, and ataxia. Besides these classic 
ﬁ ndings, irritability, headache, malaise, visual difﬁ culty, 
dysphasia, mutism, strabismus, vomiting, drooling, lethargy, 
and sleep disturbances are also present. Although often as-
sociated with neuroblastomas, ganglioneuromas and, rarely, 
hepatobastomas, the condition may be preceded by different 
viral infections, such as Epstein-Barr, St. Louis encephalitis, 
Coxsackie B3, vaccine (immunization), and aseptic meningitis 
1-5. Mycoplasma pneumoniae infection has also been associa-
ted with this syndrome. Kinsbourne syndrome occurs in 2-3% 
of neuroblastoma cases, with remission of symptoms after 
neoplasm removal 1,3,6. Typically, the tumor is small, localized, 
and well differentiated, with good prognosis. Metastasis to the 
lymph nodes located in the tumor region is frequent, althou-
gh distant metastases are rare 2. Neurological involvement, 
such as motor, cognitive, learning and speech may occur in 
the long-run 2-3. Investigation of neuroblastoma can be made 
through TC, MRI, measurement of urinary catecholamines 
(adrenal neuroblastoma) and scintigraphy with iodine-131 
metaiodobenzylguanidine, the latter being of high sensitivi-
ty and speciﬁ city, which allows the detection of neoplastic 
lesions not visualized by other imaging methods 1. Treatment 
with immunosuppressants is commonly used in patients with 
Kinsbourne syndrome regardless of etiology, and aims to 
reduce the formation of antibodies possibly involved in the 
pathophysiology 1,3. Corticosteroids, ACTH, and immunoglobu-
lins are used to reduce lymphocytic and phagocytic responses 
and production of interleukins 1,3. Rituximab, a monoclonal 
anti-CD20; cyclophosphamide; cyclosporine A; azathioprine; 
and, in refractory cases, plasmapheresis have been used to 
treat this syndrome 1-2,4,7.
Anesthesia in patients with Kinsbourne syndrome has 
rarely been reported in the literature. Burrows 8 induced 
balanced general anesthesia in a 1-year old patient with 
Kinsbourne syndrome who underwent laparotomy to remove 
a kidney tumor with spinal invasion (biopsy showed neuro-
blastoma islands surrounded by stroma of ganglioneuroma 
with neuroﬁ bromatous changes). The anesthetic technique 
consisted of morphine, pancuronium, and nitrous oxide. 
Anesthesia and surgery were uneventful, showing that 
the use of opioids, nondepolarizing muscle relaxants, and 
inhalational anesthetics seem safe in these patients. Eight 
days after surgery, a myelogram was scheduled to evalua-
te a possible involvement of the spinal cord. The patient 
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continued to present persistent opsoclonus, myoclonus, and 
ataxia. The anesthetic technique consisted of intramuscular 
atropine (0.1 mg) and ketamine (50 mg). About three minutes 
after ketamine administration, worsening of myoclonus and 
opsoclonus occurred. Prior to the procedure, we punctured 
in the peripheral vein and administered an additional dose 
of ketamine (10 mg) showing no clinical improvement. 
Then, administering intravenous thiopental (10 mg) showed 
immediate disappearance of myoclonus, allowing the pro-
cedure to continue. It is important to emphasize that when 
a neuroblastoma is located in the adrenal, catecholamine 
is released, potentiating the sympathomimetic effect of 
ketamine 5. Therefore, ketamine in patients with Kinsbourne 
syndrome should be avoided because it worsens the clinical 
picture of myoclonus and opsoclonus. Similarly, drugs that 
may induce or aggravate myoclonus, such as etomidate, 
should be avoided in these patients.
In our patient, the use of premedication with midazolam 
calmed the patient prior to arriving at the operating room 
and allowed a smooth inhalational induction. Although the 
mother reported agitation after midazolam, diazepam and 
chloral hydrate, this effect is associated with age and not 
with the pathology. The paradoxical agitation seen in children 
after the use of sedatives is common, particularly with low 
doses. The use of inhalational anesthetics (sevoﬂ urane and 
nitrous oxide), opioids (morphine and fentanyl), nondepola-
rizing neuromuscular blockers (rocuronium), analgesics and 
NSAIDs (ketoprofen and dipyrone), anticholinergics (atropine) 
and anticholinesterase (neostigmine) allowed induction, 
maintenance, and reversal from anesthesia uneventfully, 
proving to be safe in patients with Kinsbourne syndrome. 
Drugs that have the potential to trigger or aggravate myo-
clonic movements and opsoclonus - such as ketamine and 
etomidado - should be avoided.
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